Prophylactic implantation of cardioverter‐defibrillator in patients with advanced light‐chain amyloidosis—A pilot study

Documenti analoghi

• How to demonstrate the clinical implication of prophylactic implantable cardioverter–defibrillator in patients with advanced light chain amyloidosis
  di: Naoya Kataoka, et al.
  Pubblicazione: (2025)
• Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
  di: Yuki Konno, et al.
  Pubblicazione: (2025)
• Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
  di: Hirota Kida, et al.
  Pubblicazione: (2025)
• How to indicate implantable cardioverter‐defibrillator in the aging population
  di: Risako Orita, et al.
  Pubblicazione: (2025)
• Management of patients following implantable cardioverter‐defibrillator therapy—The importance of a multifaceted approach
  di: Karshana Selvarajah, et al.
  Pubblicazione: (2024)